Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 608Pancreatic Neoplasms 371Carcinoma, Hepatocellular 284Stomach Neoplasms 236Rectal Neoplasms 173Colonic Neoplasms 162Carcinoma, Non-Small-Cell Lung 160Esophageal Neoplasms 158Breast Neoplasms 138Neoplasms 126Neoplasm Metastasis 123Ovarian Neoplasms 114Lung Neoplasms 104Cholangiocarcinoma 101Liver Neoplasms 95Gastrointestinal Neoplasms 93Melanoma 82Biliary Tract Neoplasms 74Prostatic Neoplasms 71Esophageal Squamous Cell Carcinoma 66Endometrial Neoplasms 66Sarcoma 54Squamous Cell Carcinoma of Head and Neck 53Carcinoma, Renal Cell 53Uterine Cervical Neoplasms 47Adenocarcinoma Of Esophagus 45Head and Neck Neoplasms 44Urinary Bladder Neoplasms 39Triple Negative Breast Neoplasms 37Gastrointestinal Stromal Tumors 34

Interventions

irinotecan sucrosofate 1Folfox protocol 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Rectal Cancer × Gastrointestinal × 90 days × Clear all
NCT03781323 2026-06-04

Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer

University of Rochester

Phase 2 Active not recruiting
12 enrolled 9 charts
Gastrointestinal

Advanced Rectal Cancer

NCT07281157 2026-06-03

Liposomal Irinotecan, Capecitabine and Enlonstobart With Short-Course Radiotherapy for Locally Advanced Rectal Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡